The National Lipid Association has issued a position statement recommending the use of icosapent ethyl for treating patients with atherosclerotic CVD or type 2 diabetes, rooting its endorsement in the positive results of the REDUCE-IT study.

Apple announced the initiation of three new large-scale medical studies, including one focused on women’s health, one focused on hearing and one focused on cardiovascular health and movement.

Nearly two-thirds of American medical students have higher-than-average blood pressure, according to research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Native Hawaiians who struggled to control their high blood pressure and type 2 diabetes benefited greatly from a six-month hula dancing program, researchers reported at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Preliminary research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this week suggests gut bacteria could be an indicator of whether someone with high blood pressure also suffers from depression.

Motivational text messages could be the key to better glycemic control in patients with both diabetes mellitus and coronary heart disease, according to research out of China.

Research presented this month at the ESC Congress in Paris suggests that getting a yearly influenza shot could greatly cut hypertensive patients’ risk of dying during flu season.

Biomedical tech company Biobeat has received 510K clearance for its noninvasive, cuffless BP-monitoring systems.